Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Current Leases (2020 - 2026)

Outset Medical has reported Current Leases over the past 6 years, most recently at $1.7 million for Q4 2025.

  • Quarterly Current Leases fell 3.34% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 3.34% year-over-year, with the annual reading at $1.7 million for FY2025, 3.34% down from the prior year.
  • Current Leases was $1.7 million for Q4 2025 at Outset Medical, down from $1.9 million in the prior quarter.
  • Over five years, Current Leases peaked at $1.9 million in Q3 2025 and troughed at $984000.0 in Q1 2021.
  • The 5-year median for Current Leases is $1.5 million (2023), against an average of $1.5 million.
  • Year-over-year, Current Leases soared 41.82% in 2021 and then fell 3.34% in 2025.
  • A 5-year view of Current Leases shows it stood at $1.2 million in 2021, then increased by 14.51% to $1.3 million in 2022, then grew by 20.86% to $1.6 million in 2023, then rose by 12.93% to $1.8 million in 2024, then fell by 3.34% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Current Leases are $1.7 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).